Axinn Launches COVID-19 FDA Resources Page
April 17, 2020

Axinn’s FDA practice has launched the COVID-19 FDA Resources page. This new page provides resources for companies seeking information on FDA’s response to the COVID-19 pandemic by sharing selected FDA guidances on medical products. This page also shares articles authored by Axinn attorneys and other thought leadership on coronavirus-related topics.

Click here to access the COVID-19 FDA Resources page.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.